리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 06월
페이지 정보:영문 94 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 인간 인슐린 시장, 2030년에는 791억 달러에 달할 전망
2023년에 501억 달러로 추정된 세계의 인간 인슐린 시장은 2023-2030년에 CAGR 6.7%로 성장하며, 2030년에는 791억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 HI 의약품은 CAGR 6.6%를 기록하며, 분석 기간 종료까지 706억 달러에 달할 것으로 예측됩니다. HI 전달기기 부문은 향후 7년간 CAGR이 7.6%로 예측됩니다.
미국 시장은 132억 달러, 중국은 CAGR 10.2%로 성장할 것으로 예측
미국의 인간 인슐린 시장은 2023년에는 132억 달러에 달할 것으로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 189억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년의 CAGR은 10.2%입니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 각각 2023-2030년에 3.5%와 6%의 성장이 예측됩니다. 유럽에서는 독일이 CAGR 약 4%로 성장할 것으로 예측되고 있습니다.
2024년의 매력적인 신규 리포트 기능 소개
인플루언서 관여 통계에 대한 풀 액세스
디지털 아카이브와 "MarketGlass"리서치 플랫폼에 대한 무료 액세스. Global Industry Analysts, Inc.의 독자적인 MarketGlass 플랫폼은 전 세계 전문가의 창조성과 시장 지식을 통합적 및 협조적으로 활용할 수 있도록 지원합니다. Global Industry Analysts, Inc.의 최첨단 툴은 시장 참여 기업의 프라이버시와 ID를 보호하면서 세계 클래스의 시장 전망을 가져옵니다. 리포트내 수치, 통계, 시장에 관한 설명은 이 분야의 전문가 및 인플루언서에 의해 공유된 완전하게 큐레이트된 인사이트에 기반하고 있습니다.
실시간 데이터 시뮬레이터·툴 및 맞춤형 리포트 작성 기능을 갖춘 인터랙티브 앙케이트에 참가할 수 있습니다.
기업간 스마트한 의견교환을 위한 피어 협업·인터랙티브 플랫폼에 대한 풀 클라이언트 액세스
1년간 무료 리포트 업데이트
주요 기업의 세계 시장 점유율을 포함한 경쟁 커버리지
복수 지역에 걸친 기업 시장 입지 분석(호조/활발/니치/마이너)
전문가/인플루언서 인터뷰, 팟캐스트, 프레스 발표, 이벤트 기조 강연의 YouTube 비디오에 대한 액세스
2024년 세계 경제에 기대하는 것
금융긴축과 이에 따른 금리 상승에 의해 발생하는 지정학적, 경제적 불안정성이 2024년 격동의 상황을 야기할 것으로 생각됩니다. 중동에서의 적대 적대 행위 및 더욱 더 빈발하는 기후 재해 등 몇개의 요인이 회복의 길에 계속 압력을 가할 것으로 생각됩니다. 이러한 리스크 가운데 디스인플레이션의 조짐과 고질적인 인플레이션에 대한 불안감 완화, 공급망 정상화, 에너지 비용의 변동성에도 불구하고 가격 조정 등 몇 가지 긍정적인 요소도 구체화되고 있습니다. 인도 및 미국을 비롯한 G21 국가의 선거는 자본 흐름 및 투자전략에 영향을 미칠 가능성이 있습니다. 인도가 세계 투자처로서 주목받는 한편, 미국을 기반으로 하는 하이테크 기업은 재능과 자본의 역동적인 에코시스템에 의해 지원되며 계속 우위를 유지할 것으로 생각됩니다. 실리콘밸리를 비롯한 하이테크 기회는 국내 경제가 감속하고 있으나 안정적이며, 규제 환경도 정비되고 있는 것으로 인해 고성장 가능성을 요구하는 투자자에게 계속 매력적입니다. 유럽은 금융긴축정책과 경기후퇴 리스크와의 싸움이 계속되며, 영국은 전망이 가장 어렵고, 2024년 경기후퇴 리스크가 가장 높습니다. 중국은 정부지출과 개인소비의 개선에 의지한 성장이 기대되며 계속해서 와일드 카드로 남아 있습니다. 불안정한 환경은 투자자와 기업 모두에게 기회와 과제를 둘 다 제공할 것으로 생각됩니다. 성장에 대한 촉매로서 변동성을 수용하는 것과 함께 투자 판단 결정에서 민첩성과 전략적 선견성이 생존을 위해 여전히 중요할 것입니다.
조사 대상 기업의 예(총 43건)
Becton, Dickinson and Company
Biocon Limited
Biodel, Inc.
Boehringer Ingelheim International GmbH
Boston Scientific Corp.
Braun Melsungen AG
ELI Lilly and Company
Julphar(Also Known as Gulf Pharmaceutical Industries)
Medtronic Plc
Merck & Co., Inc.
NOVO Nordisk A/S
Sanofi
Tonghua Dongbao Pharmaceutical
Wockhardt Limited
Ypsomed AG
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장의 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Human Insulin Market to Reach $79.1 Billion by 2030
The global market for Human Insulin estimated at US$50.1 Billion in the year 2023, is expected to reach US$79.1 Billion by 2030, growing at a CAGR of 6.7% over the period 2023-2030. HI Drugs, one of the segments analyzed in the report, is expected to record 6.6% CAGR and reach US$70.6 Billion by the end of the analysis period. Growth in the HI Delivery Devices segment is estimated at 7.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $13.2 Billion, While China is Forecast to Grow at 10.2% CAGR
The Human Insulin market in the U.S. is estimated at US$13.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$18.9 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
Introducing Our Exciting New Report Features for 2024
Full access to influencer engagement stats
Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
Complimentary report updates for one year
Competitor coverage with global market shares of major players
Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes
What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.
Select Competitors (Total 43 Featured) -
Becton, Dickinson and Company
Biocon Limited
Biodel, Inc.
Boehringer Ingelheim International GmbH
Boston Scientific Corp.
Braun Melsungen AG
ELI Lilly and Company
Julphar (Also Known as Gulf Pharmaceutical Industries)
Medtronic Plc
Merck & Co., Inc.
NOVO Nordisk A/S
Sanofi
Tonghua Dongbao Pharmaceutical
Wockhardt Limited
Ypsomed AG
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Human Insulin - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Online Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Human Insulin Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 11: World Recent Past, Current & Future Analysis for Human Insulin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Human Insulin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Human Insulin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for HI Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for HI Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for HI Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for HI Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for HI Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for HI Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Pen Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Pen Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Pen Needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Other Delivery Options by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Other Delivery Options by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Other Delivery Options by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 32: USA Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
CANADA
TABLE 41: Canada Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
JAPAN
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 50: Japan Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
CHINA
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 59: China Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
EUROPE
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 68: Europe Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Human Insulin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Human Insulin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Human Insulin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
FRANCE
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 80: France Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: France Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: France 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 83: France Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
GERMANY
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 89: Germany Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Germany 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
ITALY
TABLE 98: Italy Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Italy 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 101: Italy Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
UNITED KINGDOM
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 107: UK Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: UK Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: UK 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 110: UK Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 113: UK Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
SPAIN
TABLE 116: Spain Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: Spain Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Spain 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 119: Spain Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Spain Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Spain 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 122: Spain Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Spain 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
RUSSIA
TABLE 125: Russia Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Russia Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Russia 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 128: Russia Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Russia Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Russia 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 131: Russia Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Russia 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Europe Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Europe 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of Europe 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Asia-Pacific Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Asia-Pacific 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Human Insulin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Human Insulin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Human Insulin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Asia-Pacific 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
AUSTRALIA
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 155: Australia Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Australia Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Australia 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 158: Australia Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Australia Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Australia 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 161: Australia Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Australia 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
INDIA
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 164: India Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: India Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: India 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 167: India Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: India Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: India 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 170: India Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: India Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: India 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 173: South Korea Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: South Korea Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: South Korea 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 176: South Korea Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: South Korea Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: South Korea 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 179: South Korea Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: South Korea 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Rest of Asia-Pacific Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Asia-Pacific Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
LATIN AMERICA
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 191: Latin America Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Latin America Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Latin America 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 194: Latin America Recent Past, Current & Future Analysis for Human Insulin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Human Insulin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Human Insulin by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 197: Latin America Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Latin America 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 203: Argentina Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Argentina Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Argentina 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 206: Argentina Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Argentina Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Argentina 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 209: Argentina Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Argentina 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
BRAZIL
TABLE 212: Brazil Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Brazil Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Brazil 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 215: Brazil Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Brazil Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Brazil 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 218: Brazil Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Brazil 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
MEXICO
TABLE 221: Mexico Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Mexico Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Mexico 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 224: Mexico Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Mexico Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Mexico 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 227: Mexico Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 229: Mexico 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 231: Rest of Latin America Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 232: Rest of Latin America 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 234: Rest of Latin America Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 235: Rest of Latin America 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 238: Rest of Latin America 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
MIDDLE EAST
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 239: Middle East Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 240: Middle East Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 241: Middle East 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 242: Middle East Recent Past, Current & Future Analysis for Human Insulin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Human Insulin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Human Insulin by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 245: Middle East Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 250: Middle East 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
IRAN
TABLE 251: Iran Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 252: Iran Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 253: Iran 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 254: Iran Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 255: Iran Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 256: Iran 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 257: Iran Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 259: Iran 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
ISRAEL
TABLE 260: Israel Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 261: Israel Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 262: Israel 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 263: Israel Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 264: Israel Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 265: Israel 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 266: Israel Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 268: Israel 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 270: Saudi Arabia Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 271: Saudi Arabia 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 273: Saudi Arabia Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 274: Saudi Arabia 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 277: Saudi Arabia 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 278: UAE Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 279: UAE Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 280: UAE 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 281: UAE Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 282: UAE Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 283: UAE 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 284: UAE Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 286: UAE 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 288: Rest of Middle East Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 289: Rest of Middle East 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 291: Rest of Middle East Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 292: Rest of Middle East 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 295: Rest of Middle East 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030
AFRICA
Human Insulin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 296: Africa Recent Past, Current & Future Analysis for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 297: Africa Historic Review for Human Insulin by Distribution Channel - Retail Pharmacy, Hospital Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 298: Africa 16-Year Perspective for Human Insulin by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Hospital Pharmacy and Online Pharmacy for the Years 2014, 2024 & 2030
TABLE 299: Africa Recent Past, Current & Future Analysis for Human Insulin by Product Type - HI Drugs and HI Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 300: Africa Historic Review for Human Insulin by Product Type - HI Drugs and HI Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 301: Africa 16-Year Perspective for Human Insulin by Product Type - Percentage Breakdown of Value Sales for HI Drugs and HI Delivery Devices for the Years 2014, 2024 & 2030
TABLE 302: Africa Recent Past, Current & Future Analysis for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Human Insulin by Delivery Type - Pens, Syringes, Pen Needles and Other Delivery Options Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 304: Africa 16-Year Perspective for Human Insulin by Delivery Type - Percentage Breakdown of Value Sales for Pens, Syringes, Pen Needles and Other Delivery Options for the Years 2014, 2024 & 2030